ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models | Science
S1, C and D). Bexarotene treatment of primary microglia and astrocytes facilitated degradation of soluble Aβ42 (fig. S2, A and ... Treatment of primary microglia or astrocytes with bexarotene stimulated the expression of apoE, ABCA1, and ABCG1 (fig. S1, A ...